$325 Million is the total value of SILVERARC CAPITAL MANAGEMENT, LLC's 70 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 62.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| QQQ | New | INVESCO QQQ TRput | $45,546,000 | – | 162,500 | +100.0% | 14.02% | – |
| ITCI | Buy | INTRA-CELLULAR THERAPIES INC | $17,921,000 | -5.2% | 313,962 | +1.7% | 5.52% | -29.4% |
| XBI | Sell | SPDR SER TRcall | $15,470,000 | -42.6% | 208,300 | -30.6% | 4.76% | -57.3% |
| BLU | Buy | BELLUS HEALTH INC NEW | $14,442,000 | +8059.3% | 1,562,957 | +26.5% | 4.45% | +5991.8% |
| VCYT | Buy | VERACYTE INC | $14,304,000 | +21.9% | 718,789 | +68.9% | 4.40% | -9.3% |
| CERS | Buy | CERUS CORP | $11,077,000 | +44.3% | 2,093,861 | +49.7% | 3.41% | +7.4% |
| MRUS | Buy | MERUS N V | $10,621,000 | +23.7% | 469,113 | +44.5% | 3.27% | -8.0% |
| AVXL | New | ANAVEX LIFE SCIENCES CORPput | $9,180,000 | – | 917,100 | +100.0% | 2.83% | – |
| MORF | Buy | MORPHIC HLDG INC | $9,085,000 | +229.3% | 418,660 | +509.3% | 2.80% | +144.9% |
| VERU | New | VERU INCput | $8,819,000 | – | 780,400 | +100.0% | 2.72% | – |
| RXDX | New | PROMETHEUS BIOSCIENCES INCput | $8,517,000 | – | 301,700 | +100.0% | 2.62% | – |
| CTIC | Sell | CTI BIOPHARMA CORP | $8,239,000 | -21.6% | 1,380,111 | -38.7% | 2.54% | -41.7% |
| ACRS | Buy | ACLARIS THERAPEUTICS INC | $7,532,000 | +58.7% | 539,545 | +96.0% | 2.32% | +18.1% |
| COGT | Buy | COGENT BIOSCIENCES INC | $7,405,000 | +72.3% | 820,954 | +43.1% | 2.28% | +28.2% |
| SGEN | Buy | SEAGEN INC | $7,217,000 | +357.4% | 40,787 | +272.3% | 2.22% | +240.3% |
| XENE | Buy | XENON PHARMACEUTICALS INC | $7,077,000 | +395.6% | 232,630 | +130.1% | 2.18% | +268.7% |
| KRYS | Buy | KRYSTAL BIOTECH INC | $6,912,000 | +123.5% | 105,277 | +126.5% | 2.13% | +66.2% |
| MRTX | New | MIRATI THERAPEUTICS INCcall | $6,773,000 | – | 100,900 | +100.0% | 2.08% | – |
| APLS | Buy | APELLIS PHARMACEUTICALS INC | $5,869,000 | +9.6% | 129,795 | +23.2% | 1.81% | -18.5% |
| ALNY | New | ALNYLAM PHARMACEUTICALS INCcall | $5,834,000 | – | 40,000 | +100.0% | 1.80% | – |
| HZNP | Buy | HORIZON THERAPEUTICS PUB L | $5,758,000 | -18.9% | 72,187 | +7.0% | 1.77% | -39.6% |
| ORIC | New | ORIC PHARMACEUTICALS INC | $4,849,000 | – | 1,082,304 | +100.0% | 1.49% | – |
| CFRX | New | CONTRAFECT CORPput | $4,798,000 | – | 1,562,900 | +100.0% | 1.48% | – |
| BIIB | Buy | BIOGEN INC | $4,247,000 | +1746.5% | 20,825 | +103.2% | 1.31% | +1276.8% |
| INSM | Buy | INSMED INC | $4,190,000 | +74.7% | 212,482 | +108.2% | 1.29% | +29.9% |
| ISEE | Buy | IVERIC BIO INCput | $4,145,000 | +160.4% | 430,900 | +355.5% | 1.28% | +93.6% |
| MRSN | New | MERSANA THERAPEUTICS INC | $3,927,000 | – | 850,000 | +100.0% | 1.21% | – |
| APEN | Buy | APOLLO ENDOSURGERY INC | $3,923,000 | -35.4% | 1,074,879 | +7.0% | 1.21% | -52.0% |
| BHVN | Sell | BIOHAVEN PHARMACTL HLDG CO L | $3,843,000 | -11.8% | 26,374 | -74.3% | 1.18% | -34.4% |
| UTHR | Buy | UNITED THERAPEUTICS CORP DEL | $3,824,000 | +43.7% | 16,227 | +9.4% | 1.18% | +6.8% |
| IMTX | Sell | IMMATICS N.V | $3,093,000 | -13.1% | 355,103 | -20.3% | 0.95% | -35.3% |
| VRTX | Buy | VERTEX PHARMACEUTICALS INC | $2,935,000 | +47.3% | 10,414 | +36.3% | 0.90% | +9.6% |
| CGEM | New | CULLINAN ONCOLOGY INC | $2,732,000 | – | 213,090 | +100.0% | 0.84% | – |
| CRNX | Buy | CRINETICS PHARMACEUTICALS IN | $2,602,000 | +4.0% | 139,539 | +22.4% | 0.80% | -22.6% |
| RGNX | New | REGENXBIO INC | $2,572,000 | – | 104,129 | +100.0% | 0.79% | – |
| AKRO | New | AKERO THERAPEUTICS INC | $2,460,000 | – | 260,325 | +100.0% | 0.76% | – |
| MRTX | Sell | MIRATI THERAPEUTICS INC | $2,444,000 | -35.5% | 36,403 | -21.1% | 0.75% | -52.1% |
| OTIC | Sell | OTONOMY INC | $2,166,000 | -25.3% | 1,041,273 | -13.8% | 0.67% | -44.4% |
| Buy | ELIEM THERAPEUTICS INC | $2,153,000 | +190.6% | 713,009 | +707.7% | 0.66% | +116.0% | |
| SNDX | Buy | SYNDAX PHARMACEUTICALS INC | $2,075,000 | +17.7% | 107,852 | +6.3% | 0.64% | -12.5% |
| PHR | New | PHREESIA INC | $1,954,000 | – | 78,111 | +100.0% | 0.60% | – |
| VRAY | Buy | VIEWRAY INC | $1,942,000 | +13.6% | 732,740 | +68.0% | 0.60% | -15.4% |
| DAWN | New | DAY ONE BIOPHARMACEUTICALS I | $1,888,000 | – | 105,476 | +100.0% | 0.58% | – |
| IMGN | Sell | IMMUNOGEN INC | $1,874,000 | -39.0% | 416,479 | -35.4% | 0.58% | -54.6% |
| CVRX | New | CVRX INC | $1,756,000 | – | 292,145 | +100.0% | 0.54% | – |
| EYPT | Buy | EYEPOINT PHARMACEUTICALS INC | $1,555,000 | -31.1% | 197,640 | +6.4% | 0.48% | -48.7% |
| CDXS | Buy | CODEXIS INC | $1,443,000 | -13.6% | 137,960 | +70.3% | 0.44% | -35.7% |
| HGEN | New | HUMANIGEN INCput | $1,383,000 | – | 781,100 | +100.0% | 0.43% | – |
| NKTX | New | NKARTA INC | $1,365,000 | – | 110,763 | +100.0% | 0.42% | – |
| AMYT | Buy | AMRYT PHARMA PLCsponsored ads | $1,232,000 | -2.8% | 176,309 | +15.0% | 0.38% | -27.8% |
| MCRB | Buy | SERES THERAPEUTICS INC | $1,193,000 | -48.7% | 347,761 | +6.4% | 0.37% | -61.9% |
| NGM | Sell | NGM BIOPHARMACEUTICALS INC | $1,132,000 | -63.0% | 88,303 | -56.0% | 0.35% | -72.4% |
| ZYME | New | ZYMEWORKS INC | $1,104,000 | – | 208,330 | +100.0% | 0.34% | – |
| PSTX | Buy | POSEIDA THERAPEUTICS INC | $982,000 | -8.6% | 380,606 | +58.8% | 0.30% | -32.0% |
| CLDX | Sell | CELLDEX THERAPEUTICS INC NEW | $979,000 | +282.4% | 36,322 | -20.2% | 0.30% | +184.0% |
| CLDX | New | CELLDEX THERAPEUTICS INC NEWput | $971,000 | – | 36,000 | +100.0% | 0.30% | – |
| SBTX | New | SILVERBACK THERAPEUTICS INC | $887,000 | – | 209,108 | +100.0% | 0.27% | – |
| PYPD | Sell | POLYPID LTD | $750,000 | -37.0% | 161,572 | -25.9% | 0.23% | -53.1% |
| STXS | Buy | STEREOTAXIS INC | $678,000 | -47.5% | 368,648 | +6.4% | 0.21% | -60.9% |
| FMTX | Sell | FORMA THERAPEUTICS HLDGS INC | $650,000 | -60.0% | 94,386 | -46.0% | 0.20% | -70.2% |
| CCXI | New | CHEMOCENTRYX INC | $645,000 | – | 26,036 | +100.0% | 0.20% | – |
| BCRX | Sell | BIOCRYST PHARMACEUTICALS INC | $566,000 | +187.3% | 53,521 | -47.7% | 0.17% | +112.2% |
| MGTX | New | MEIRAGTX HLDGS PLC | $394,000 | – | 52,066 | +100.0% | 0.12% | – |
| ELOX | Sell | ELOXX PHARMACEUTICALS INC | $281,000 | -74.3% | 1,041,499 | -46.6% | 0.09% | -80.8% |
| CGEN | Sell | COMPUGEN LTDord | $193,000 | -77.7% | 104,150 | -61.2% | 0.06% | -83.5% |
| MREO | Sell | MEREO BIOPHARMA GROUP PLCads | $175,000 | -33.7% | 156,195 | -33.7% | 0.05% | -50.5% |
| EVGN | Sell | EVOGENE LTD | $156,000 | -59.4% | 202,322 | -31.6% | 0.05% | -69.8% |
| ALGS | Buy | ALIGOS THERAPEUTICS INC | $71,000 | +208.7% | 58,392 | +447.8% | 0.02% | +120.0% |
| MSACW | MEDICUS SCIENCES ACQUISITION*w exp 02/12/202 | $9,000 | -57.1% | 49,990 | 0.0% | 0.00% | -66.7% | |
| RENOVACOR INC*w exp 99/99/999 | $6,000 | -81.8% | 104,828 | 0.0% | 0.00% | -85.7% | ||
| BNTC | Exit | BENITEC BIOPHARMA INC | $0 | – | -492,880 | -100.0% | -0.02% | – |
| CALA | Exit | CALITHERA BIOSCIENCES INC | $0 | – | -221,809 | -100.0% | -0.03% | – |
| Exit | AMYLYX PHARMACEUTICALS INC | $0 | – | -30,000 | -100.0% | -0.16% | – | |
| APTX | Exit | APTINYX INCput | $0 | – | -201,600 | -100.0% | -0.19% | – |
| IMUX | Exit | IMMUNIC INC | $0 | – | -68,475 | -100.0% | -0.32% | – |
| NXTC | Exit | NEXTCURE INC | $0 | – | -196,187 | -100.0% | -0.39% | – |
| LHDX | Exit | LUCIRA HEALTH INC | $0 | – | -310,734 | -100.0% | -0.46% | – |
| MSAC | Exit | MEDICUS SCIENCES ACQUISITION | $0 | – | -131,151 | -100.0% | -0.53% | – |
| CYCC | Exit | CYCLACEL PHARMACEUTICALS INC | $0 | – | -462,659 | -100.0% | -0.58% | – |
| IMGN | Exit | IMMUNOGEN INCcall | $0 | – | -300,000 | -100.0% | -0.59% | – |
| ASND | Exit | ASCENDIS PHARMA A/Ssponsored adr | $0 | – | -25,000 | -100.0% | -0.59% | – |
| ASLN | Exit | ASLAN PHARMACEUTICALS LTDads | $0 | – | -500,000 | -100.0% | -0.66% | – |
| PNT | Exit | POINT BIOPHARMA GLOBAL INC | $0 | – | -204,679 | -100.0% | -0.68% | – |
| JNCE | Exit | JOUNCE THERAPEUTICS INC | $0 | – | -248,347 | -100.0% | -0.70% | – |
| LPTX | Exit | LEAP THERAPEUTICS INC | $0 | – | -1,032,163 | -100.0% | -0.75% | – |
| NBIX | Exit | NEUROCRINE BIOSCIENCES INC | $0 | – | -20,482 | -100.0% | -0.80% | – |
| VRDN | Exit | VIRIDIAN THERAPEUTICS INC | $0 | – | -126,136 | -100.0% | -0.96% | – |
| GLPG | Exit | GALAPAGOS NVspon adr | $0 | – | -41,002 | -100.0% | -1.05% | – |
| ITOS | Exit | ITEOS THERAPEUTICS INC | $0 | – | -138,843 | -100.0% | -1.85% | – |
| SRRA | Exit | SIERRA ONCOLOGY INC | $0 | – | -443,381 | -100.0% | -5.88% | – |
| ATHA | Exit | ATHIRA PHARMA INC | $0 | – | -10,000 | -100.0% | -11.16% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-07-25
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| INTRA-CELLULAR THERAPIES INC | 12 | Q3 2023 | 7.8% |
| IMMUNOGEN INC | 12 | Q3 2023 | 8.3% |
| Morphic Holding Inc | 12 | Q3 2023 | 4.5% |
| UNUM THERAPEUTICS INC | 12 | Q3 2023 | 3.2% |
| INSMED INC | 12 | Q3 2023 | 3.5% |
| UNITED THERAPEUTICS CORP DEL | 12 | Q3 2023 | 2.2% |
| MERUS N V | 11 | Q3 2023 | 5.1% |
| VERACYTE INC | 11 | Q3 2023 | 4.9% |
| EVOGENE LTD | 11 | Q3 2023 | 1.6% |
| COMPUGEN LTD | 11 | Q3 2023 | 1.1% |
View SILVERARC CAPITAL MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Benitec Biopharma Inc.Sold out | February 08, 2023 | 0 | 0.0% |
| DELCATH SYSTEMS, INC.Sold out | February 08, 2022 | 0 | 0.0% |
View SILVERARC CAPITAL MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| SC 13G/A | 2023-02-08 |
| 13F-HR | 2022-10-28 |
View SILVERARC CAPITAL MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.